InvestorsHub Logo
Followers 18
Posts 1429
Boards Moderated 2
Alias Born 07/29/2012

Re: trader59 post# 44122

Thursday, 05/09/2024 11:04:14 AM

Thursday, May 09, 2024 11:04:14 AM

Post# of 44408
Remember that NIH through the CRADA will be paying MOST of the IND costs for the AMD trial (all except travel expenses). CUBT has to pay to provide the drug, but NIH will pay for the trial.

CUBT needs to raise enough money to qualify to be uplisted to the NYSE/Amex.